No Data
No Data
No Data
No Data
No Data
Skye Bioscience to Present at Upcoming Investment Conferences
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of
GlobeNewswireApr 23 19:00
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with t
BenzingaApr 20 01:25
Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler
Seeking AlphaApr 12 23:34
Skye Bioscience Initiated at Outperform by Oppenheimer
Skye Bioscience Initiated at Outperform by Oppenheimer
Dow JonesApr 12 17:37
Skye Bioscience (SKYE.US) was first covered by Oppenheimer, which gave it an superior market rating, with a target price of $25.00.
Skye Bioscience (SKYE.US) was first covered by Oppenheimer, which gave it an superior market rating, with a target price of $25.00.
Zhitong FinanceApr 12 17:31
Oppenheimer Initiates Coverage On Skye Bioscience With Outperform Rating, Announces Price Target of $25
Oppenheimer analyst Jay Olson initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Outperform rating and announces Price Target of $25.
BenzingaApr 12 17:27
No Data
No Data